Upregulation of the 5-lipoxygenase pathway in human monocytes by growth and differentiation factors

Author： Wagner M.   Werz O.   Steinhilber D.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.7, 2013-07, pp. : 578-583

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibitors of the 5-Lipoxygenase Pathway in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 15, Iss. 27, 2009-09 ,pp. : 3116-3132

Bentham Science Publishers

Access to resources Recommend Favorite

Effect of Growth Differentiation Factor 5 on the Proliferation and Tenogenic Differentiation Potential of Human Mesenchymal Stem Cells in vitro

By  

Cells Tissues Organs, Vol. 196, Iss. 4, 2012-05 ,pp. : 325-338

Karger

Access to resources Recommend Favorite

The potential link between atherosclerosis and the 5-lipoxygenase pathway: investigational agents with new implications for the cardiovascular field

By Whatling Carl   McPheat William   Herslöf Margareta  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1879-1893

Informa Healthcare

Access to resources Recommend Favorite

Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells

By Hofmanova J.   Kozubk A.   Dusek L.   Pachernk J.  

European Journal of Pharmacology, Vol. 350, Iss. 2, 1998-06 ,pp. : 273-284

Elsevier

Access to resources Recommend Favorite

Growth Differentiation Factor 5 Regulation in Bone Regeneration

By  

Current Pharmaceutical Design, Vol. 19, Iss. 19, 2013-06 ,pp. : 3364-3373

Bentham Science Publishers

Access to resources Recommend Favorite